期刊文献+

Non-invasive diagnosis of H pylori infection: Evaluation of serological tests with and without current infection marker CIM 被引量:4

Non-invasive diagnosis of H pylori infection:Evaluation of serological tests with and without current infection marker CIM
下载PDF
导出
摘要 AIM:To evaluate the performance of commercially available immunochromatographic (ICT) and immunoblot tests covering the current infection marker CIM and conventional ELISA for the diagnosis of H pylori infection in adult dyspeptic patients. METHODS:Consecutive non-treated dyspeptic patients undergoing diagnostic endoscopy were tested for H pylori infection by culture, rapid urease test, and histology of gastric biopsy specimens. Serum from 61 H pylori infected and 21 non-infected patients were tested for anti-H pylori IgG antibodies by commercial ELISA (AccuBindTM ELISA, Monobind, USA), ICT (Assure H pylori Rapid Test, Genelabs Diagnostics, Singapore), and immunoblot (Helico Blot 2.1, Genelabs Diagnostics, Singapore) assays. ICT and immunoblot kits cover CIM among other parameters and their performance with and without CIM was evaluated separately. RESULTS:Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of ELISA were 96.7%, 42.8%, 83.1%, 81.8%, and 82.9%, of ICT were 90.1%, 80.9%, 93.2%, 73.9%, and 87.8%, of ICT with CIM were 88.5%, 90.4%, 96.4%, 73.0%, and 89.0%, of immunoblot were 98.3%, 80.9%, 93.7%, 94.4%, and 93.9%, and of immunoblot with CIM were 98.3%, 90.4%, 96.7%, 95.0%, and 96.3%, respectively. CONCLUSION:Immunoblot with CIM had the best performance. ICT with CIM was found to be more specific and accurate than the conventional ELISA and may be useful for non-invasive diagnosis of H pylori infection. AIM: TO evaluate the performance of commercially available immunochromatographic (ICT) and immunoblot tests covering the current infection marker CIM and conventional ELISA for the diagnosis of Hpylori infection in adult dyspeptic patients.METHODS: Consecutive non-treated dyspeptic patients undergoing diagnostic endoscopy were tested for H pylori infection by culture, rapid urease test, and histology of gastric biopsy specimens. Serum from 61 H pylori infected and 21 non-infected patients were tested for anti-H pylori IgG antibodies by commercial ELISA (AccuBindTM ELISA, Monobind, USA), ICT (Assure H pylori Rapid Test, Genelabs Diagnostics, Singapore), and immunoblot (Helico Blot 2.1, Genelabs Diagnostics, Singapore) assays. ICT and immunoblot kits cover CIM among other parameters and their performance with and without CIM was evaluated separately.RESULTS: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of ELISA were 96.7%, 42.8%, 83.1%, 81.8%, and 82.9%, of ICT were 90.1%, 80.9%, 93.2%, 73.9%, and 87.8%, of ICT with CIM were 88.5%, 90.4%, 96.4%, 73.0%, and 89.0%, of immunoblot were 98.3%, 80.9%, 93.7%, 94.4%, and 93.9%, and of immunoblot with CIM were 98.3%, 90.4%, 96.7%, 95.0%, and 96.3%, respectively.CONCLUSION: Immunoblot with CIM had the best performance, ICT with CIM was found to be more specific and accurate than the conventional ELISA and may be useful for non-invasive diagnosis of Hpylori infection.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第8期1231-1236,共6页 世界胃肠病学杂志(英文版)
基金 SIDA Grant, No. GR-00384 to MotiurRahman
关键词 H pylori ELISA Immunochromatographic test IMMUNOBLOT Current infection marker 幽门 免疫色谱法测试 细菌感染 诊断
  • 相关文献

参考文献32

  • 1[1]Marshall BJ,Warren JR.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.Lancet 1984; 1:1311-1315
  • 2[2]Marshall BJ,McGechie DB,Rogers PA,Glancy RJ.Pyloric Campylobacter infection and gastroduodenal disease.Med J Aust 1985; 142:439-444
  • 3[3]Graham DY,Lew GM,Klein PD,Evans DG,Evans DJ Jr,Saeed ZA,Malaty HM.Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer.A randomized,controlled study.Ann Intern Med 1992; 116:705-708
  • 4[4]Hosking SW,Ling TK,Chung SC,Yung MY,Cheng AF,Sung JJ,Li AK.Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment:randomised controlled trial.Lancet 1994; 343:508-510
  • 5[5]Sung JJ,Chung SC,Ling TK,Yung MY,Leung VK,Ng EK,Li MK,Cheng A.F,Li AK.Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.N Engl J Med 1995;332:139-142
  • 6[6]Current European concepts in the management of Helicobacter pylori infection.The Maastricht Consensus Report.European Helicobacter pylori Study Group.Gut 1997;41:8-13
  • 7[7]Lassen AT,Hallas J,Schaffalitzky de Muckadell OB.Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients:6.7 year follow up of a randomised trial.Gut 2004; 53:1758-1763
  • 8[8]Lane JA,Murray LJ,Noble S,Egger M,Harvey IM,Donovan JL,Nair P,Harvey RF.Impact of Helicobacter pylori eradication on dyspepsia,health resource use,and quality of life in the Bristol helicobacter project:randomised controlled trial.BMJ 2006; 332:199-204
  • 9[9]Shaw IS,Valori RM,Charlett A,McNulty CA.Limited impact on endoscopy demand from a primary care based'test and treat'dyspepsia management strategy:the results of a randomised controlled trial.Br J Gen Pract 2006; 56:369-374
  • 10[10]Vaira D,Gatta L,Ricci C,Miglioli M.Review article:diagnosis of Helicobacter pylori infection.Aliment Pharmacol Ther 2002;16 Suppl 1:16-23

同被引文献29

  • 1Bo Sun Zhao-Shen Li Zhen-Xing Tu Guo-Ming Xu Yi-Qi Du.Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity[J].World Journal of Gastroenterology,2006,12(43):7042-7046. 被引量:4
  • 2Jyh-Ming Liou,Chieh-Chang Chen,Mei-Jyh Chen,Chien-Chuan Chen,Chi-Yang Chang,Yu-Jen Fang,Ji–Yuh Lee,Shih-Jer Hsu,Jiing-Chyuan Luo,Wen-Hsiung Chang,Yao-Chun Hsu,Cheng-Hao Tseng,Ping-Huei Tseng,Hsiu-Po Wang,Ueng-Cheng Yang,Chia-Tung Shun,Jaw-Town Lin,Yi-Chia Lee,Ming-Shiang Wu.Sequential versus triple therapy for the first-line treatment of Helicobacter pylori : a multicentre, open-label, randomised trial[J].The Lancet.2012
  • 3Javier Molina‐Infante,Carmen Pazos‐Pacheco,Gema Vinagre‐Rodriguez,Belen Perez‐Gallardo,Carmen Due?as‐Sadornil,Moisés Hernandez‐Alonso,Guadalupe Gonzalez‐Garcia,Jose M. Mateos‐Rodriguez,Miguel Fernandez‐Bermejo,Javier P. Gisbert.Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin‐Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin‐Resistant Strains[J].Helicobacter.2012(4)
  • 4Zulfikar Polat,Abdurrahman Kadayifci,Murat Kantarcioglu,Ayhan Ozcan,Ozdes Emer,Ahmet Uygun.Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori[J].European Journal of Internal Medicine.2011(2)
  • 5Yuji Maehata,Shotaro Nakamura,Kiyoshi Fujisawa,Motohiro Esaki,Tomohiko Moriyama,Kouichi Asano,Yuta Fuyuno,Kan Yamaguchi,Issei Egashira,Hyonji Kim,Motonobu Kanda,Minako Hirahashi,Takayuki Matsumoto.Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer[J].Gastrointestinal Endoscopy.2012(1)
  • 6Xue-Ying Tian,Hong Zhu,Jing Zhao,Qiang She,Guo-Xin Zhang.Diagnostic Performance of Urea Breath Test, Rapid Urea Test, and Histology for Helicobacter pylori Infection in Patients With Partial Gastrectomy: A Meta-analysis[J].Journal of Clinical Gastroenterology.2012(4)
  • 7Gaia Codolo,Fleur Bossi,Paolo Durigutto,Chiara Della Bella,Fabio Fischetti,Amedeo Amedei,Francesco Tedesco,Sofia D’Elios,Marco Cimmino,Alessandra Micheletti,Marco A. Cassatella,Mario M. D’Elios,Marina de Bernard.Orchestration of Inflammation and Adaptive Immunity in Borrelia burgdorferi –Induced Arthritis by Neutrophil‐Activating Protein A[J].Arthritis & Rheumatism.2013(5)
  • 8Shin‐ichi Yokota,Nariaki Toita,Soh Yamamoto,Nobuhiro Fujii,Mutsuko Konno.Positive Relationship Between a Polymorphism in H elicobacter pylori Neutrophil‐Activating Protein A Gene and Iron‐Deficiency Anemia[J].Helicobacter.2012(2)
  • 9Ianko D. Iankov,Alan R. Penheiter,Stephanie K. Carlson,Evanthia Galanis.Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein[J].Journal of Immunological Methods (-).2012(1-2)
  • 10Gaia Codolo,Matteo Fassan,Fabio Munari,Andrea Volpe,Piefrancesco Bassi,Massimo Rugge,Francesco Pagano,Mario Milco D’Elios,Marina Bernard.HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response[J].Cancer Immunology Immunotherapy.2012(1)

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部